GlobeNewswire by notified

Telstra Ventures-backed LambdaTest expands in the ANZ Region

Share

LambdaTest provides an enterprise execution environment for organizations undergoing rapid digital transformation. Backed by Telstra Ventures, LambdaTest addresses the growing demand for secure and compliant test execution infrastructure within their private cloud.

San Francisco, May 22, 2023 (GLOBE NEWSWIRE) -- LambdaTest, a leading intelligent digital experience testing cloud, announced that its innovative solution for test execution and orchestration now supports private cloud in the Australia and New Zealand (ANZ) region.

By offering flexible deployment options for its unified Enterprise Execution Environment (E3) within the private cloud of an enterprise, LambdaTest addresses security and privacy concerns, while revolutionizing test execution and orchestration for ANZ enterprises that are undergoing rapid digital transformation.

As more and more ANZ enterprises are moving towards a digital-first approach, having a seamless digital experience is becoming important for organizations to maintain their bottom lines. For faster digital feature releases, they need to also test their features faster, which often becomes a bottleneck in continuous processes. Adopting cloud-based continuous testing mitigates this challenge, however, for data security and other compliance-conscious organizations, adopting public cloud solutions becomes a roadblock.

Recognizing the paramount importance of security and compliance, LambdaTest offers a unique solution with its intelligent Enterprise Execution Environment (E3) that can be deployed in customer private cloud infrastructure within the ANZ region. LambdaTest allows enterprises to have complete control over their testing environments, ensuring compliance with industry regulations while maintaining data security.

Enterprises can efficiently orchestrate and run their tests within their private cloud and also adhere to data protection, confidentiality, security, and compliance for applications under test. With Just in-time capabilities, enterprises can scale their test execution infrastructure while optimizing their costs and resources and accelerating time-to-market.

"The ANZ region is experiencing an accelerated pace of digital transformation, and LambdaTest is excited to be at the forefront of this evolution by providing a highly reliable and intelligent test orchestration and execution platform to cater to enterprises in the region," said Jay Singh, Co-Founder at LambdaTest. "We understand the security and compliance concerns in the region and enterprises can now orchestrate and run their tests at a massive scale within their private cloud using LambdaTest’s Enterprise Execution Environment."

LambdaTest's entry into the Australia and New Zealand region is supported by Telstra Ventures. This partnership showcases the confidence and support for LambdaTest's innovative approach to test execution and orchestration.

Steve Schmidt, General Partner at Telstra Ventures said, “As software is being more embedded into our daily lives, more companies are being forced to build or significantly enhance their software factories.  Given the sheer scale and velocity of new software being developed, companies are needing to automate as much of the testing process as possible.  While LambdaTest already has over 2M users, supporting the private cloud deployment option will open new markets to customers needing the highest levels of security and compliance”.

With its entry into Australia and New Zealand region, LambdaTest aims to be a catalyst in transforming the way enterprises execute and orchestrate their tests. By providing a comprehensive and secure testing solution, LambdaTest empowers organizations to enhance the quality of their applications, improve time to market, and accelerate their digital transformation initiatives.

About Telstra Ventures:
Telstra Ventures identifies what’s next, right now. Telstra Ventures serves extraordinary leaders and helps them achieve their dreams. In our first ten years, 92 investments have generated 37 liquidity events including Auth0, BigCommerce, Box, Cloopen, CrowdStrike, DocuSign, Rancher, Skillz, Snap, and Whispir. To date, our Revenue Acceleration Platform has driven > A$750 million in revenue for our portfolio companies, extending their reach across Australia, Asia, UK and the US. In 2022, we announced the close of our third fund, bringing Funds Under Management to A$1.3 billion, making us one of the largest VCs in the ANZ region. To see our full portfolio and learn more, visit www.telstraventures.com

About LambdaTest

LambdaTest is an intelligent unified digital experience testing cloud that helps businesses drastically reduce time to market through faster test execution, ensuring quality releases and accelerated digital transformation. Over 10,000+ enterprise customers and 2+ million users across 130+ countries rely on LambdaTest for their testing needs.

Browser & App Testing Cloud allows users to run both manual and automated tests of web and mobile apps across 3000+ different browsers, real devices, and operating system environments.

HyperExecute helps customers run and orchestrate test grids in the cloud for any framework and programming language at blazing-fast speeds to cut down on quality test time, helping developers build software faster.

For more information, please visit, https://lambdatest.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certification6.5.2024 23:25:48 CEST | Press release

Global healthcare certification leader convenes experts to discuss ultrasound training and certification as key strategy to reduce maternal mortality ROCKVILLE, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, will host a roundtable discussion titled "Advancing Maternal and Fetal Health through POCUS Training and Certification" on May 29 alongside a side event during the WHO World Health Assembly and the AI for Good Global Summit. The roundtable will explore the urgent need to expand point-of-care ultrasound (POCUS) training and certification for frontline maternal health clinicians as a crucial intervention for reducing preventable maternal deaths and achieving UN Sustainable Development Goals, and how to implement to scale. Despite the increased availability of affordable ultrasound technology, there remains a significant training gap that limits access to this diagnostic tool, especially in low-resource areas with high matern

ETC’s Commercial/Industrial Units Awarded Three Contracts Totaling $15.9 Million6.5.2024 22:15:00 CEST | Press release

SOUTHAMPTON, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation’s (OTC Pink: ETCC) (“ETC” or the “Company”) Sterilization Systems Group announced it has been awarded $13.9 million in contracts from two multi-national medical device manufacturers. The contracts include four, sixteen pallet ethylene oxide (“EO”) sterilization system chambers with related conveyer systems, and a large capacity vacuum drying chamber with preconditioning. “These contracts reflect ETC Sterilization Systems Group’s dedication to innovation in our mechanical designs, control systems and software expertise to meet the challenging requirements of this market,” states Eric Hunnicutt, ETC Director of EO Sterilizer Sales. ETC’s Sterilization Systems Group offers Steam and Ethylene Oxide (“EO”) Sterilizer Systems, Vacuum Dryers, Software Systems, and project management services to the Medical Device, Pharmaceutical, Biotechnology, and Life Science industries. ETC’s systems are specially design

Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC6.5.2024 22:05:00 CEST | Press release

If approved, Zeno will be the first targeted therapy for NRG1+ cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a Biologics License Application (BLA) for the bispecific antibody zenocutuzumab (Zeno) in patients with neuregulin 1 fusion (NRG1+) non-small cell lung (NSCLC) and NRG1+ pancreatic (PDAC) cancer. “FDA acceptance of our first BLA represents an important achievement for Merus and an important potential treatment opportunity for patients with NRG1+ cancer, a disease with poor prognosis and high unmet need,” said Dr. Andrew Joe, Chief Medical Officer at Merus. “Zenocutuzumab has the potential to be the first and only targeted therapy for patients with NRG1+ lung and

Nokia Corporation: Repurchase of own shares on 06.05.20246.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 06 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.05.2024 Espoo, Finland – On 06 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6823.45CEUX--BATE--AQEU--TQEX--Total385,6823.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Trading in Novo Nordisk shares by board members, executives and associated persons6.5.2024 21:02:16 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated a) Name of the Board member/Executive/Associated Person Novo Holdings A/S, associated to Kasim Kutay 2 Reason for the notification a) Position/status Member of the Board of Directors b) Initial notification/Amendment Initial notification 3 Details of the issuer a) Name Novo Nordisk A&S b) LEI 549300DAQ1CVT6CXN342

HiddenA line styled icon from Orion Icon Library.Eye